Skip to main content

Table 2 Frequency of MSC production, proliferation potential and delivery methods for therapeutic targets in different body organs, as compared with BM-MSCs

From: Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015)

Different sources of MSCs

Frequency of productiona

Potential of proliferationa

Delivery methods for regeneration

References

Bone marrow

1 in 3.4 × 104 cells

Intravenously

[332]

Umbilical cord matrix

Low

High

Not specified

[128, 333]

Amnion

High

Low

Not specified

[334]

Placenta

High

High

Not specified

[128]

Adipose tissue

High

High

Not specified

[55, 105, 128]

Peripheral blood

High

High

Intravenously

[128, 335]

Cord blood

Low

High

Intramyocardial, intravenous, intracoronary

[103, 336, 337]

  1. aIn comparison with the BM-MSCs
  2. BM-MSC bone marrow-derived mesenchymal stem cell, MSC mesenchymal stem cell